2011
DOI: 10.1016/j.ijrobp.2010.01.033
|View full text |Cite
|
Sign up to set email alerts
|

Longitudinal Study of Intestinal Symptoms and Fecal Continence in Patients With Conformal Radiotherapy for Prostate Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 36 publications
1
1
0
Order By: Relevance
“…DVH data of the herein analyzed patient group compare favorably to the data of a patient sample that was treated previously with 3D conformal radiotherapy to doses of 74 Gy at our institution using 10 mm margins without daily image guidance [8]. Rectal V35, V50, and V65 in that sample were 47%, 35%, and 22% as compared to 48%, 27%, and 14%, respectively, in the present study.…”
Section: Discussionsupporting
confidence: 64%
“…DVH data of the herein analyzed patient group compare favorably to the data of a patient sample that was treated previously with 3D conformal radiotherapy to doses of 74 Gy at our institution using 10 mm margins without daily image guidance [8]. Rectal V35, V50, and V65 in that sample were 47%, 35%, and 22% as compared to 48%, 27%, and 14%, respectively, in the present study.…”
Section: Discussionsupporting
confidence: 64%
“…These traits underlying clinical symptoms, such as bone loss, osteoporotic fractures [66][67][68], and for high-dose radiation treatment, pelvic pain [67], were deeply analyzed up to a year post-RT [68]. Patients suffered from rectal bleeding and fecal continence as a post-treatment side-effect to prostate cancer therapy [69] and reduced BMD following their cervical cancer radiation treatment, often depending on their age and age-related menopausal status [68]. Bone loss was further determined for RT plus androgen deprivation therapy in case of locally advanced prostate cancer [70].…”
Section: Microbiota Influence Rt and Clinical Datamentioning
confidence: 99%